small molecule

IZBA

TRAVOPROST

Loss of exclusivityOctober 2029latest FDA-listed patent expiry
CompanyNovartisView the full company profile on CliffBio

Drug detail

Brand nameIZBA
Active ingredientTRAVOPROST
Strength0.003% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage formSOLUTION/DROPS
RouteOPHTHALMIC
ModalitySmall molecule
FDA approvalMay 2014
Marketing statusDISCN

Listed patents

PatentExpiresType
8722735October 2029product
8178582October 2029product
8754123May 2029product
9144561March 2029product

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

IZBA patent cliff — loss of exclusivity October 2029 | CliffBio